The purification and identification of human blood serum proteins with affinity to the antitumor active RL2 lactaptin using magnetic microparticles
Author | Manko N. |
Author | Starykovych M. |
Author | Bobak Y. |
Author | Stoika R. |
Author | Richter V. |
Author | Koval O. |
Author | Lavrik I. |
Author | Horák D. |
Author | Souchelnytskyi S. |
Author | Kit Y. |
Available date | 2020-04-05T10:53:21Z |
Publication Date | 2019 |
Publication Name | Biomedical Chromatography |
Resource | Scopus |
ISSN | 2693879 |
Abstract | The cytopoxic effect of RL2 lactaptin (the recombinant analog of proteolytic fragment of human kappa‐casein) toward tumor cells in vitro and in vivo presents it as a novel promising antitumor drug. The binding of any drug with serum proteins can affect their activity, distribution, rate of excretion and toxicity in the human body. Here, we studied the ability of RL2 to bind to various blood serum proteins. Using magnetic microparticles bearing by RL2 as an affinity matrix, in combination with mass spectrometry and western blot analysis, we found a number of blood serum proteins possessing affinity for RL2. Among them IgA, IgM and IgG subclasses of immunoglobulins, apolipoprotein A1 and various cortactin isoforms were identified. This data suggests that in the bloodstream RL2 lactaptin takes part in complicate protein–protein interactions, which can affect its activity. |
Sponsor | This work was financial supported by Volkswagen Foundation (grant # VW 90315). |
Language | en |
Publisher | John Wiley and Sons Ltd |
Subject | human blood serum proteins identification magnetic microparticles mass spectrometry and western blotting purification RL2 antitumor agent |
Type | Article |
Issue Number | 11 |
Volume Number | 33 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Medicine Research [1418 items ]